VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
36 hedge funds and large institutions have $47.1M invested in VIVEVE MED INC in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 15 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $49.6M → $47.1M (-$2.47M)
15% less call options, than puts
Call options by funds: $93K | Put options by funds: $109K
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
22% less funds holding
Funds holding: 46 → 36 (-10)
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$810K |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$567K |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
+$150K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$133K |
| 5 |
Squarepoint
New York
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$1.2M |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$950K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$876K |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$856K |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$728K |
VIVE Hedge Fund Activity: Q3 2018 in Review
36 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q3 2018, worth a combined $47.1M — down 5% from $49.6M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of VIVE and 5 opened new positions — a net loss of 10 holders — while 14 trimmed existing stakes and 11 added.
The largest buyer was RTW Investments, adding an estimated $810K. The largest seller was Marshall Wace, exiting entirely with an estimated $1.2M sold.
- 36 institutional investors held VIVEVE MED INC (VIVE) as of Q3 2018, down from 46 in Q2 2018.
- Funds reported $47.1M of VIVEVE MED INC stock for Q3 2018, down 5% quarter-over-quarter.
- 5 funds opened new VIVEVE MED INC positions in Q3 2018 and 15 closed out, a net change of -10 holders.
- The largest VIVEVE MED INC buyer in Q3 2018 was RTW Investments, an estimated $810K added.
- The largest VIVEVE MED INC seller in Q3 2018 was Marshall Wace, an estimated $1.2M sold.
Based on aggregated 13F filings for Q3 2018.